Cite
HARVARD Citation
McCrimmon, R. et al. (2022). Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial. Diabetes, obesity & metabolism. 24 (12), pp. 2391-2399. [Online].